TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,492,846 | -20.5% | 657,039 | +136.1% | 0.02% | -18.2% |
| Q2 2023 | $6,913,171 | +52.1% | 278,308 | -7.9% | 0.02% | +37.5% |
| Q1 2023 | $4,544,923 | -53.5% | 302,189 | -63.4% | 0.02% | -30.4% |
| Q4 2022 | $9,779,258 | +42.0% | 826,649 | -28.9% | 0.02% | +64.3% |
| Q3 2022 | $6,885,000 | +47.7% | 1,163,051 | +6.1% | 0.01% | +100.0% |
| Q2 2022 | $4,660,000 | -73.1% | 1,096,369 | -39.7% | 0.01% | -58.8% |
| Q1 2022 | $17,304,000 | -51.5% | 1,819,544 | -3.2% | 0.02% | -41.4% |
| Q4 2021 | $35,702,000 | -36.6% | 1,879,078 | +11.0% | 0.03% | -52.5% |
| Q3 2021 | $56,332,000 | +61.8% | 1,692,671 | +88.6% | 0.06% | +45.2% |
| Q2 2021 | $34,821,000 | +47.1% | 897,690 | +82.7% | 0.04% | +20.0% |
| Q1 2021 | $23,679,000 | +174.8% | 491,256 | +196.6% | 0.04% | +133.3% |
| Q4 2020 | $8,616,000 | +10.9% | 165,626 | -42.9% | 0.02% | -37.5% |
| Q3 2020 | $7,768,000 | +211.3% | 290,302 | +126.6% | 0.02% | +100.0% |
| Q2 2020 | $2,495,000 | +303.7% | 128,092 | +103.9% | 0.01% | +140.0% |
| Q1 2020 | $618,000 | -39.1% | 62,815 | -31.3% | 0.01% | -28.6% |
| Q4 2019 | $1,015,000 | +271.8% | 91,435 | +87.8% | 0.01% | +250.0% |
| Q3 2019 | $273,000 | -69.1% | 48,692 | -55.7% | 0.00% | -80.0% |
| Q1 2019 | $883,000 | +47.4% | 109,826 | -24.8% | 0.01% | +100.0% |
| Q4 2018 | $599,000 | -26.6% | 146,034 | +0.3% | 0.01% | -16.7% |
| Q3 2018 | $816,000 | -68.7% | 145,645 | -26.5% | 0.01% | -72.7% |
| Q2 2018 | $2,604,000 | +1.0% | 198,049 | +9.1% | 0.02% | -15.4% |
| Q1 2018 | $2,577,000 | +135.6% | 181,477 | +36.0% | 0.03% | +225.0% |
| Q4 2017 | $1,094,000 | -2.5% | 133,393 | +40.9% | 0.01% | -20.0% |
| Q3 2017 | $1,122,000 | -10.0% | 94,682 | -23.6% | 0.01% | -23.1% |
| Q2 2017 | $1,246,000 | +201.7% | 123,963 | +249.3% | 0.01% | +160.0% |
| Q1 2017 | $413,000 | +1620.8% | 35,489 | +602.2% | 0.01% | – |
| Q4 2016 | $24,000 | +33.3% | 5,054 | +114.7% | 0.00% | – |
| Q3 2016 | $18,000 | +157.1% | 2,354 | +104.0% | 0.00% | – |
| Q2 2016 | $7,000 | -65.0% | 1,154 | -50.7% | 0.00% | – |
| Q1 2016 | $20,000 | -95.2% | 2,340 | -93.3% | 0.00% | -100.0% |
| Q4 2015 | $417,000 | -57.9% | 34,986 | -64.4% | 0.01% | -64.3% |
| Q3 2015 | $991,000 | -2.0% | 98,317 | +61.3% | 0.01% | 0.0% |
| Q2 2015 | $1,011,000 | +82.8% | 60,934 | +70.6% | 0.01% | +55.6% |
| Q1 2015 | $553,000 | +144.7% | 35,720 | +150.7% | 0.01% | +200.0% |
| Q4 2014 | $226,000 | -54.0% | 14,248 | -69.0% | 0.00% | -62.5% |
| Q3 2014 | $491,000 | +5.6% | 46,032 | -7.0% | 0.01% | +14.3% |
| Q2 2014 | $465,000 | +91.4% | 49,484 | +40.3% | 0.01% | +75.0% |
| Q1 2014 | $243,000 | +1004.5% | 35,280 | +526.5% | 0.00% | – |
| Q4 2013 | $22,000 | – | 5,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |